GSVlabs Completes $7 Million Series B Financing Round, Names CEO To Lead Global Growth Strategy New Funding + CEO Announcement

SMC Biotechnology

SMC Biotechnology, Inc. (SMC Bio) is a privately held, early clinical stage regenerative medicine company developing best-in-class, pro‑healing medical devices and tissue regenerative products. Our lead products are medical devices that optimize healing by pairing the Company’s core technology, Tissue‑Targeted Glycosaminoglycans (TT-GAGs), with FDA cleared, commercially available biomaterials and scaffolds to facilitate the natural healing and tissue regeneration processes.


Follow GSVlabs

Amazing Things Happen Here

Sign up for email updates to stay connected with GSVlabs.